Abstract
The effects of the combination of E-1040, a new cephalosporin, ceftazidime, cefpirome, or cefepime with tobramycin against 40 Pseudomonas aeruginosa and 16 P. cepacia isolates from cystic fibrosis patients were examined. Synergy fractional inhibitory concentration less than or equal to 0.5 was found against P. aeruginosa when tobramycin was combined with E-1040 32%, cefpirome 32%, cefepime 22%, and ceftazidime 22%. Fifty-two percent of isolates showed an additive response for E-1040, 60% for cefpirome, 45% cefepime, and 55% ceftazidime, p greater than 0.05. The differences were not statistically significant. Synergy was not more likely to be achieved if the isolates were susceptible or resistant to either the aminoglycoside or cephalosporin. None of the E-1040-resistant isolates, all of which were tobramycin-resistant, became susceptible when tested with an aminoglycoside, whereas 15 of 34 cefpirome-resistant, 13 of 30 cefepime-resistant, and seven of 14 ceftazidime-resistant isolates became susceptible. Synergy of aminoglycoside and the cephalosporins against P. cepacia was found for 25% with E-1040, 44% with cefpirome, 38% with cefepime, and 31% with ceftazidime. These differences were not statistically significant.
References
May 1, 1978·Antimicrobial Agents and Chemotherapy·H C Neu, K P Fu
Apr 1, 1989·Antimicrobial Agents and Chemotherapy·J A BossoJ M Matsen
Nov 1, 1988·Antimicrobial Agents and Chemotherapy·H C NeuA Novelli
Jul 1, 1987·The Pediatric Infectious Disease Journal·R PadoanA Giunta
Mar 1, 1988·Antimicrobial Agents and Chemotherapy·W J Brown
Apr 1, 1986·The Journal of Antimicrobial Chemotherapy·H C NeuP Labthavikul
Nov 1, 1986·Pediatric Pulmonology·S C Aronoff, P H Labrozzi
May 1, 1986·The Journal of Pediatrics·A Prince
May 1, 1985·Antimicrobial Agents and Chemotherapy·P C FuchsC Thornsberry
Nov 1, 1985·Reviews of Infectious Diseases·J D Allan, R C Moellering
Nov 1, 1985·Reviews of Infectious Diseases·B E ScullyH C Neu
May 1, 1985·Infection·H C NeuP Labthavikul
Jul 1, 1985·Antimicrobial Agents and Chemotherapy·D A ConradM I Marks
Dec 1, 1971·The Journal of Infectious Diseases·V T Andriole
Mar 1, 1983·The Journal of Infectious Diseases·F J McLaughlinD A Goldmann
Jan 1, 1984·Archives of Internal Medicine·B E Scully, H C Neu
Feb 1, 1984·The Journal of Pediatrics·A IslesH Levison
Apr 1, 1984·Antimicrobial Agents and Chemotherapy·H GiamarellouJ Bouzos
Feb 1, 1984·Antimicrobial Agents and Chemotherapy·S C Aronoff, J D Klinger
Jun 1, 1984·Antimicrobial Agents and Chemotherapy·R N JonesA L Barry
Jun 1, 1982·Antimicrobial Agents and Chemotherapy·R K ScribnerD F Welch
Citations
Jan 13, 2006·European Journal of Clinical Microbiology & Infectious Diseases : Official Publication of the European Society of Clinical Microbiology·B BalkeS Häussler
Mar 9, 2004·Journal of Microbiological Methods·Michael M Tunney, Eileen M Scott
Nov 22, 1997·Diagnostic Microbiology and Infectious Disease·E J Giamarellos-BourboulisH Giamarellou
Dec 31, 2002·The Journal of Infection·T E Mc ManusJ S Elborn
Dec 1, 1991·Antimicrobial Agents and Chemotherapy·J Fung-TomcR E Kessler
Aug 1, 1994·Thorax·D PeckhamA J Knox
Nov 21, 2001·Pharmacotherapy·C A RobinsonJ E Kanga
Nov 12, 2003·Drugs·Susan M CheerStuart Noble
Aug 28, 2004·Journal of Chemotherapy·C TasciniF Menichetti
Jun 3, 2008·FEMS Microbiology Letters·Puthayalai TreeratAnthony M George
Aug 14, 2009·FEMS Microbiology Letters·Anthony M GeorgePeter G Middleton
Jan 30, 1999·Antimicrobial Agents and Chemotherapy·S BonacorsiE Bingen
Mar 1, 1996·Antimicrobial Agents and Chemotherapy·D M Cappelletty, M J Rybak